title: Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit.
abstract: BACKGROUND
  Mutations in the gene encoding the human cardiac Na(+) channel alpha-subunit (hH1) are responsible for chromosome 3-linked congenital long-QT syndrome (LQT3) and idiopathic ventricular fibrillation (IVF). An auxiliary beta(1)-subunit, widely expressed in excitable tissues, shifts the voltage dependence of steady-state inactivation toward more negative potentials and restores normal gating kinetics of brain and skeletal muscle Na(+) channels expressed in Xenopus oocytes but has little if any functional effect on the cardiac isoform. Here, we characterize the altered effects of a human beta(1)-subunit (hbeta(1)) on the heterologously expressed hH1 mutation (T1620M) previously associated with IVF.
  
  
  RESULTS
  When expressed alone in Xenopus oocytes, T1620M exhibited no persistent currents, in contrast to the LQT3 mutant channels, but the midpoint of steady-state inactivation (V(1/2)) was significantly shifted toward more positive potentials than for wild-type hH1. Coexpression of hbeta(1) did not significantly alter current decay or recovery from inactivation of wild-type hH1; however, it further shifted the V(1/2) and accelerated the recovery from inactivation of T1620M. Oocyte macropatch analysis revealed that the activation kinetics of T1620M were normal.
  
  
  CONCLUSIONS
  It is suggested that coexpression of hbeta(1) exposes a more severe functional defect that results in a greater overlap in the relationship between channel inactivation and activation (window current) in T1620M, which is proposed to be a potential pathophysiological mechanism of IVF in vivo. One possible explanation for our finding is an altered alpha-/beta(1)-subunit association in the mutant.
authors.affiliation: Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo, Japan. makitan@med.hokudai.ac.jp
authors.forename: N
authors.initials: N
authors.lastname: Makita
authors.forename: N
authors.initials: N
authors.lastname: Shirai
authors.forename: D W
authors.initials: DW
authors.lastname: Wang
authors.forename: K
authors.initials: K
authors.lastname: Sasaki
authors.forename: A L
authors.initials: AL
authors.lastname: George
authors.forename: M
authors.initials: M
authors.lastname: Kanno
authors.forename: A
authors.initials: A
authors.lastname: Kitabatake
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D002462:Cell Membrane / Q000502:physiology; D002874:Chromosome Mapping; D002893:Chromosomes, Human, Pair 3; D006321:Heart / Q000503:physiopathology*; D006801:Humans; D015640:Ion Channel Gating; D007700:Kinetics; D008133:Long QT Syndrome / Q000235:genetics* / Q000503:physiopathology; D046911:Macromolecular Substances; D008564:Membrane Potentials; D009206:Myocardium / Q000378:metabolism; D009865:Oocytes / Q000502:physiology; D017433:Protein Structure, Secondary; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D015222:Sodium Channels / Q000737:chemistry / Q000235:genetics* / Q000502:physiology*; D013577:Syndrome; D014693:Ventricular Fibrillation / Q000235:genetics* / Q000503:physiopathology; D014981:Xenopus
chemical_list: D046911:Macromolecular Substances; D011994:Recombinant Proteins; D015222:Sodium Channels